Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost
暂无分享,去创建一个
E. Frenkel | Eugene Frenkel | R. Sarode | Yu-Min Shen | Judy Tsai | Evelyn Taiwo | Chakri Gavva | Sean G Yates | Vivek Patel | Ravi Sarode | Yu-min P Shen | Chakri Gavva | S. Yates | Vivek Patel | Judy P. Tsai | E. Taiwo
[1] Kenneth R Carson,et al. The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. , 2013, Blood.
[2] O. Egeberg. Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.
[3] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[4] Elaine Gray,et al. Clinical guidelines for testing for heritable thrombophilia , 2010, British journal of haematology.
[5] S. Machin,et al. Pros and cons of thrombophilia testing: cons , 2003, Journal of thrombosis and haemostasis : JTH.
[6] E. Harris,et al. The antiphospholipid syndrome , 1995, Clinical reviews in allergy & immunology.
[7] Matthew D. Krasowski,et al. Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center , 2015, BMC Medical Informatics and Decision Making.
[8] M. García-Carrasco,et al. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome? , 1997, Clinical and experimental rheumatology.
[9] P. Romundstad,et al. Incidence and mortality of venous thrombosis: a population‐based study , 2007, Journal of thrombosis and haemostasis : JTH.
[10] J. Sánchez-Guerrero,et al. Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus. , 1989, The Journal of rheumatology.
[11] C. Esmon,et al. Familial protein S deficiency is associated with recurrent thrombosis. , 1984, The Journal of clinical investigation.
[12] R. Kistner,et al. Thrombophilia testing has limited usefulness in clinical decision-making and should be used selectively. , 2015, Journal of vascular surgery. Venous and lymphatic disorders.
[13] W. Geerts. Prevention of venous thromboembolism: a key patient safety priority , 2009, Journal of thrombosis and haemostasis : JTH.
[14] H. Cohen,et al. Guidelines On The Investigation and Management Of The Antiphospholipid Syndrome , 2000, British journal of haematology.
[15] O. Rawley,et al. Elevated factor VIII levels and risk of venous thrombosis , 2012, British journal of haematology.
[16] T. Barbui,et al. Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S , 1994, Thrombosis and Haemostasis.
[17] Ian Mackie,et al. Guidelines on the investigation and management of antiphospholipid syndrome , 2012, British journal of haematology.
[18] Samuel G. Johnson,et al. Thrombophilia testing patterns amongst patients with acute venous thromboembolism. , 2015, Thrombosis research.
[19] M Greaves,et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. , 2006, Health technology assessment.
[20] P. Reitsma,et al. Genetic risk factors for venous thrombosis. , 2000, Molecular genetics and metabolism.
[21] D. Jackson,et al. A New Inherited Coagulation Disorder Caused by an Abnormal Fibrinogen (‘Fibrinogen Baltimore’) , 1965, Nature.
[22] J. Griffin,et al. Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.
[23] Giuseppe Lippi,et al. Laboratory investigation of thrombophilia: the good, the bad, and the ugly. , 2009, Seminars in thrombosis and hemostasis.
[24] S. Das,et al. Congenital thrombophilia among patients with venous thromboembolism , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[25] Paolo Prandoni,et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[26] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[27] M. Fisher,et al. Testing for Inherited Thrombophilias in Arterial Stroke: Can It Cause More Harm Than Good? , 2010, Stroke.